BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210817
DTEND;VALUE=DATE:20210820
DTSTAMP:20260515T205138
CREATED:20210409T153003Z
LAST-MODIFIED:20210413T084608Z
UID:29760-1629158400-1629417599@www.pharmajournalist.com
SUMMARY:Prostate Cancer Drug Development Digital Summit
DESCRIPTION:The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma\, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery\, translation\, and clinical development of safe and effective treatments for prostate cancer. \n \nHere’s a sneak peek of crucial topics to be addressed: \n\nAmgen examining Bi-specific T-cell engager immune therapies for the treatment of prostate cancer ​​​​​​\nNovartis and Advanced Accelerator Applications revealing PSMA\, re-envision survival\n​​​​​​Noxopharm evaluating whether Veyonda is the answer to safe and effective prostate cancer treatment\nThe National Cancer Institute and the National Institutes of Health teaching optimization potential role for immunotherapy in biochemically recurrent prostate cancer\nThe University of Texas\, MD Anderson Cancer Center demonstrating strategies for overcoming the immunosuppressive prostate tumor microenvironment and whether there is still a role for chemotherapy and chemotherapy combinations\n\nTo find out more and view the 2021 speaker line-up\, download the full event guide. \nJoin 60+ thought-leaders converging at the first industry-led meeting to gain the latest scientific insights with renowned Urologists/Oncologists and those striving to advance safe and effective therapeutic breakthroughs to patients in need. \nTo know more about Prostate Cancer Drug Development Digital Summit please click here.
URL:https://www.pharmajournalist.com/event/prostate-cancer-drug-development-digital-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210817
DTEND;VALUE=DATE:20210820
DTSTAMP:20260515T205138
CREATED:20210514T082011Z
LAST-MODIFIED:20210514T084343Z
UID:30139-1629158400-1629417599@www.pharmajournalist.com
SUMMARY:Integrin-Targeted Drug Discovery Summit
DESCRIPTION:The excitement surrounding integrins has been growing over the past few years\, culminating in recent clinical success\, innovative biology and medicinal chemistry advancements blazing the way to tackle previously undruggable disease modalities through novel integrin targets \nThe Integrin-Targeted Drug Discovery Summit is not just the first\, but the only industry-driven event sharing pioneering advances\, expert insights and exclusive updates on the field of integrin drug discovery and development – from solid tumors to autoimmune diseases\, from ophthalmology to fibrosis\, revealing the therapeutic windows of integrins! \nWith the vast potential of integrins as targets\, this inaugural 3-day summit will unite industry trailblazers including Pliant Therapeutics\, Morphic Therapeutics and 7 Hills Pharma with academic leaders\, such as pioneer Dean Sheppard\, to delve into the biology and chemistry of different integrins classes\, MoA and explore the best approach to regulate integrins\, driving translational and clinical success. \nJoin a global community of 80+ experts on August 17-19 to tackle issues of safety\, selectivity and specificity in drug development\, further your understanding of the structure and function of integrins to inform your R&D decisions and leverage the lessons learned over the past 20 years to enhance your bed to bedside progression. \nFind out more >> https://ter.li/g4kols
URL:https://www.pharmajournalist.com/event/integrin-targeted-drug-discovery-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR